NL-OMON45738
Not yet recruiting
Not Applicable
Cell-free DNA as a new, minimally invasive and sensitive biomarker for early detection of allograft rejection after heart transplantation - cfDNA for detection of heart transplant rejection
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Erasmus MC, Universitair Medisch Centrum Rotterdam
- Enrollment
- 60
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Adult (\*18 years) heart transplant patients
Exclusion Criteria
- •No written informed consent
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Cell-free DNA: a Non-invasive Test for Assessing Embryo QualityCulture MediaDNANCT01397136IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy600
Completed
Not Applicable
Development of a Cell Free DNA Assay as a Biomarker for Predicting Early Non-response to Therapy in Metastatic CancerMetastatic Non-Small Cell Lung CarcinomaMetastatic Colorectal CancerMetastatic Breast CancerNCT03892096Cadex Genomics130
Not yet recruiting
Not Applicable
DNA repair assay for tumor response prediction in cervical cancer to radiotherapyCTRI/2024/07/069714Indian Council of Medical Research
Completed
Not Applicable
Development of Non-invasive Cell-free DNA to Supplant Invasive Biopsy in Heart TransplantationHeart TransplantNCT05309382Natera, Inc.147
Not yet recruiting
Not Applicable
A highly-sensitive cell free DNA assay in gastrointestinal tumors - A prospective observational studyGastrointestinal malignant tumorsJPRN-UMIN000050428Aichi Cancer Network500